Journal of Clinical Endocrinology & Metabolism, Vol 80, 3608-3612, Copyright © 1995 by Endocrine Society

ARTICLES

Effect of glucocorticosteroid treatment on glucocorticoid receptor expression in human adipocytes

M Bronnegard, S Reynisdottir, C Marcus, P Stierna and P Arner
Department of Pediatrics, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden.

The influence of glucocorticoid excess on expression of the glucocorticoid receptor (GR) and beta-adrenoceptor subtype was studied in isolated adipocytes obtained by sc fat biopsies from 17 healthy individuals. The biopsies were taken before and after 7 days of treatment with 25 mg prednisolone, given orally. GR and beta 1- and beta 2-adrenoceptor messenger ribonucleic acid (mRNA) levels were measured with a solution hybridization assay, and the number of beta 1- and beta 2-adrenoceptor binding sites was determined in radioligand binding experiments. GR protein levels were determined by Western blot analysis using an anti-GR antibody. Both GR protein and GR mRNA levels decreased significantly (P < 0.05) by about 50% after treatment, whereas no significant changes were demonstrated in either beta 1- or beta 2-adrenoceptor mRNA levels. The number of beta 2-adrenoceptor- binding sites, however, increased by 70% after treatment (P < 0.05), whereas the number of beta 1-adrenoceptor binding sites was not affected. The affinity of each receptor subtype was not significantly altered by steroid treatment. In conclusion, an in vivo glucocorticoid excess decreases GR mRNA as well as GR protein levels and selectively increases beta 2-adrenoceptor density in sc fat cells of healthy individuals. This indicates that glucocorticoids modulate human adipose metabolism by altering the expression of regulatory proteins at various mRNA and post-mRNA levels.

This article has been cited by other articles:

				G. Ortiz-Colon, A. C. Grant, M. E. Doumit, and D. D. Buskirk Bovine intramuscular, subcutaneous, and perirenal stromal-vascular cells express similar glucocorticoid receptor isoforms, but exhibit different adipogenic capacity J Anim Sci, June 1, 2009; 87(6): 1913 - 1920. [Abstract] [Full Text] [PDF]

				O. Paulmyer-Lacroix, S. Boullu, C. Oliver, M.-C. Alessi, and M. Grino Expression of the mRNA Coding for 11{beta}-Hydroxysteroid Dehydrogenase Type 1 in Adipose Tissue from Obese Patients: An in Situ Hybridization Study J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2701 - 2705. [Abstract] [Full Text] [PDF]

				I. J. Bujalska, S. Kumar, M. Hewison, and P. M. Stewart Differentiation of Adipose Stromal Cells: The Roles of Glucocorticoids and 11{beta}-Hydroxysteroid Dehydrogenase Endocrinology, July 1, 1999; 140(7): 3188 - 3196. [Abstract] [Full Text]

				M. L. Ricketts, J. M. Verhaeg, I. Bujalska, A. J. Howie, W. E. Rainey, and P. M. Stewart Immunohistochemical Localization of Type 1 11{beta}-Hydroxysteroid Dehydrogenase in Human Tissues J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1325 - 1335. [Abstract] [Full Text]

				J. S. Samra, M. L. Clark, S. M. Humphreys, I. A. MacDonald, P. A. Bannister, and K. N. Frayn Effects of Physiological Hypercortisolemia on the Regulation of Lipolysis in Subcutaneous Adipose Tissue J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 626 - 631. [Abstract] [Full Text]

				S. Papaspyrou-Rao, S. H. Schneider, R. N. Petersen, and S. K. Fried Dexamethasone Increases Leptin Expression in Humans in Vivo J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1635 - 1637. [Abstract] [Full Text] [PDF]